Market Rotation: UnitedHealth Gains as JPMorgan and Micron Pressure Stock Futures

Stock futures showed a distinct split in premarket trading on Tuesday, October 13, 2026, as a rare earnings miss from JPMorgan Chase weighed on the financial sector while UnitedHealth Group’s upward guidance revision bolstered defensive stocks. Dow Jones Industrial Average futures edged up 0.1%, but Nasdaq-100 futures slipped 0.6% as a sell-off in the semiconductor space deepened.

Banking stocks faced pressure after reported its first decline in fixed-income trading revenue in two years.

The early market rotation reflects a cautious start to the third-quarter earnings season. Investors are pivoting away from growth-oriented technology names toward value and healthcare sectors, following a significant guidance upgrade from the nation’s largest private health insurer.

Banking and Finance

JPMorgan Chase reported third-quarter earnings that trailed Wall Street estimates. The firm posted earnings per share (EPS) of $5.57, missing the $5.75 consensus forecast. Managed revenue reached $50.9 billion, an 8% increase year-over-year, but still fell short of the $51.23 billion analysts had anticipated.

While total net income rose 6% compared to the same period last year, specific business units showed signs of softening. Fixed-income trading revenue dropped 4%, marking the first decline for that segment in two years. This underperformance in capital markets overshadowed the bank’s moderate gains in net interest income.

Wells Fargo also saw its shares slip by roughly 1% to 3.4% premarket, despite reporting a profit increase driven by loan growth. The decline suggests a broader sector-wide cooling as investors assess whether peak interest rate benefits for the major lenders have begun to normalize.

Healthcare and Defensive Moves

Bucking the downward trend in the Dow, UnitedHealth Group shares gained ground after the company posted a significant earnings beat and raised its full-year outlook. The insurer reported adjusted third-quarter earnings of $4.69 per share, comfortably ahead of the $4.14 expected by analysts.

According to its third quarter results, UnitedHealth now expects full-year 2026 adjusted earnings to reach at least $20.50 per share, up from its previous range of $19.50 to $20.00. A key driver for this performance was an improvement in the medical care ratio—the percentage of premiums spent on healthcare services—which fell to 88.4% from 89.9% a year ago.

Conversely, Johnson & Johnson shares dipped 2.7% premarket. While the company’s pharmaceutical business remained steady, revenue from its medical-device surgery segment fell short of expectations for the quarter, dampening sentiment for the MedTech giant.

bucked the market trend by raising its full-year earnings outlook to at least $20.50 per share.

Semiconductor Jitters

Micron Technology shares fell approximately 3% premarket, leading a broader decline in chip stocks. The move followed reports that Chinese competitor ChangXin Memory Technologies (CXMT) has made technical breakthroughs in “4F square” (4F²) server-memory architecture.

Industry analysts indicate that the development of 4F² memory cells could allow CXMT to produce high-density DRAM more efficiently, potentially threatening the margins and market share of established players like Micron in the global server-memory supply chain. The news added to existing volatility in the semiconductor sector, which has faced mounting pressure over the sustainability of AI-driven demand and increasing international competition.

The post Market Rotation: UnitedHealth Gains as JPMorgan and Micron Pressure Stock Futures appeared first on World Weekly News.